Sudden death: Managing the patient who survives

Heart

Volumn 97, Issue 19, 2011, Pages 1619-1625

  Pachón, Marta ^a   Almendral, Jesús ^b  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; METOPROLOL; PROPAFENONE; SOTALOL;

ANGIOCARDIOGRAPHY; BRUGADA SYNDROME; CARDIAC IMAGING; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CATHETER ABLATION; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; DEFIBRILLATION; ELECTROCARDIOGRAPHY; HEART ARREST; HEART ELECTROPHYSIOLOGY; HEART REPOLARIZATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART SURGERY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MYOCARDITIS; NONISCHEMIC CARDIOMYOPATHY; PATIENT ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SHORT QT SYNDROME; SUDDEN DEATH; SURVIVOR;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CARDIOPULMONARY RESUSCITATION; CATHETER ABLATION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 80052650024     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.188375     Document Type: Review

References (22)

1. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989;117:151-9. (Pubitemid 19043766)
2. Ortiz M, Almendral J, Lopez-Palop R, et al. Determinants of inducibility of ventricular tachycardia. Am J Cardiol 2001;87:1255-9. (Pubitemid 32493865)
3. Bigger JT Jr, Whang W, Rottman JN, et al. Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 1999;99:1416-21. This article describes the causes of death in the CABG Patch trial and explains the greater ICD benefit found in the MADIT trial. (Pubitemid 29140905)
4. Kelly P, Ruskin JN, Vlahakes GJ, et al. Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol 1990;15:267-73. (Pubitemid 20067477)
5. Haissaguerre M, Shoda M, Jais P, et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation 2002;106:962-7. This study demonstrates the feasibility of eliminating or decreasing the incidence of idiopathic VF by catheter ablation of the sources, dominantly originating from the specialised intraventricular conducting system. (Pubitemid 34925331)
6. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40. The first randomised study demonstrating that the implantation of an ICD provided effective protection against death in high risk patients with coronary heart disease and left ventricular dysfunction. (Pubitemid 26428217)
7. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
8. Singh JP, Hall WJ, McNitt S, et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 2005;46:1712-20. A prospective analysis of the role of clinical, laboratory, echocardiographic, and electrophysiological variables as predictors of appropriate initial ICD therapy for malignant ventricular arrhythmias or death in the MADIT II population. (Pubitemid 41531628)
9. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. This study raised the standard of care for patients with ischaemic cardiac heart failure (CHF) by substantiating evidence from earlier trials in favour of ICD therapy in those patients and by providing evidence of a survival benefit associated with such therapy in patients with non-ischaemic CHF. (Pubitemid 40110811)
10. Chugh SS, Kelly KL, Titus JL, et al. Sudden cardiac death with apparently normal heart. Circulation 2000;102:649-54. (Pubitemid 30640665)
11. Krahn AD, Healy JS, Chauchan V, et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation 2009;120:278-85. A prospective multicentre experience demonstrating that systematic, rigorous clinical testing can determine the cause of unexplained cardiac arrest in more than half of all patients.
12. AVID Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-83. The largest trial comparing ICD vs antiarrhythmic drugs in secondary prevention, which concluded that overall survival was greater with the ICD.
13. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302. (Pubitemid 30158618)
14. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54. (Pubitemid 30648765)
15. AVID Investigators. Causes of death in the antiarrhythmic versus implantable defibrillators (AVID) trial. The AVID Investigators. J Am Coll Cardiol 1999;34:1552-9.
16. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 2003;138:445-52.
17. Lee DS, Green LD, Liu PP, et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol 2003;41:1573-82. (Pubitemid 36543378)
18. Conolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator Study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000;21:2071-8. An important meta-analysis of the three main randomised trials of ICD therapy versus medical treatment for the prevention of death in survivors of VF or sustained VT.
19. Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006;295:165-71. (Pubitemid 43076435)
20. Carbucicchio C, Santamaria M, Trevisi N, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 2008;117:462-9. A prospective study of patients with either coronary artery disease, idiopathic dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy suggesting that early catheter ablation may benefit patients with electrical storm.
21. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-65. A randomised trial in which prophylactic catheter ablation of arrhythmogenic ventricular tissue reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for secondary prevention of sudden death.
22. Kuck KH, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010;375:31-40.